Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020

Rhea-AI Summary

Aethlon Medical, Inc. (AEMD) will release its financial results for Q2 FY2021 on October 28, 2020, at 4:15 PM ET. The results will cover the period ending September 30, 2020. A conference call will follow at 4:30 PM ET, allowing management to discuss the outcomes and recent developments. Interested participants can register online for the conference call or dial in using the toll-free or international numbers provided. Aethlon focuses on unmet health needs, particularly with its Aethlon Hemopurifier®, a device for treating cancer and viral infections.

Positive

• Aethlon Hemopurifier® is FDA designated as a 'Breakthrough Device' for treating advanced or metastatic cancer, enhancing its market potential.
• Ownership of 80% of Exosome Sciences, Inc. positions Aethlon to leverage advancements in biomarker discovery for cancer and neurological diseases.

Negative

• None.

SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its second quarter fiscal year 2021, ended September 30, 2020, at 4:15 pm Eastern time on Wednesday, October 28, 2020.

Management will host a conference call on Wednesday, October 28, 2020 at 4:30 pm eastern time to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.

Interested parties can register for the conference by navigating to https://dpregister.com/sreg/10149369/dbcc2bc6ad. Please note that registered participants will receive their dial in number upon registration.

Interested parties without internet access or unable to pre-register may dial in by calling:
PARTICIPANT DIAL IN (TOLL FREE):	1-844-836-8741
PARTICIPANT INTERNATIONAL DIAL IN:	1-412-317-5442
All callers should ask for the Aethlon Medical, Inc. conference call.

A replay of the call will be available approximately one hour after the end of the call through November 4, 2020. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada Toll Free at 1-855-669-9658. The replay conference ID number is 10149369.

About Aethlon Medical, Inc.

Aethlon Medical is focused on addressing unmet needs in global health.  The Aethlon Hemopurifier® is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier® depletes the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis and inhibit the benefit of leading cancer therapies. The Hemopurifier® is an FDA designated "Breakthrough Device" related to the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease cancer. The Hemopurifier also holds a Breakthrough Device designation related to life-threatening viruses that are not addressed with approved therapies.

Additionally, Aethlon owns 80% of Exosome Sciences, Inc., which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disease progression. Additional information can be found online at www.AethlonMedical.com and www.ExosomeSciences.com. 

Company Contact:
Jim Frakes
Chief Financial Officer
Aethlon Medical, Inc. 
Jfrakes@aethlonmedical.com

Media Contact:
Tony Russo, Ph.D.
Russo Partners, LLC
tony.russo@russopartnersllc.com
212-845-4251

Investor Contact:
Susan Noonan
S.A. Noonan Communications, LLC
susan@sanoonan.com 
212-966-3650

View original content:http://www.prnewswire.com/news-releases/aethlon-medical-to-release-second-quarter-financial-results-and-host-conference-call-on-october-28-2020-301154411.html

SOURCE Aethlon Medical, Inc.

FAQ

When will Aethlon Medical release its Q2 FY2021 financial results?

Aethlon Medical will release its Q2 FY2021 financial results on October 28, 2020, at 4:15 PM ET.

What is the focus of Aethlon Medical's Aethlon Hemopurifier®?

The Aethlon Hemopurifier® aims to combat cancer by depleting circulating tumor-derived exosomes, and it targets life-threatening viral infections.

How can I participate in the Aethlon Medical conference call?

Interested parties can register for the conference call on Aethlon's website or dial in at 1-844-836-8741 (toll-free) or 1-412-317-5442 (international).

What date will the Aethlon Medical conference call take place?

The conference call will occur on October 28, 2020, at 4:30 PM ET.

What recent corporate developments will be discussed during the Aethlon Medical conference call?

The call will review financial results and provide updates on recent corporate developments.